UnitedHealth Group said in a court filing it is working with Amedisys to identify potential buyers for at least 128 home ...

UnitedHealth Group has withdrawn its motion to dismiss the Justice Department’s ongoing antitrust challenge to a proposed ...

UnitedHealth Group and Amedisys outlined plans to divest a significant number of home health and hospice locations as they ...

UnitedHealth Group said its motion to dismiss the DOJ lawsuit was moot after the agency cited which regions would be impacted ...

UnitedHealth Group Inc. is withdrawing its motion to dismiss the Justice Department’s lawsuit seeking to block its $3.3 ...

UnitedHealth Group Inc. (NYSE: UNH) is dropping its motion to dismiss the U.S. Department of Justice’s (DOJ) antitrust lawsuit regarding the company’s ...

UnitedHealth Group says the Justice Department’s antitrust challenge to its proposed $3.3 billion purchase of Amedisys is wrong on the merits and threatens to deprive consumers of benefits from ...

In a report released on January 29, Whit Mayo from Leerink Partners reiterated a Hold rating on Amedisys (AMED – Research Report), with a price ...

Amedisys' expected merger with UnitedHealth Group's Optum brings optimism to investors. Yet, a dull macroeconomic condition adds to the worry. In a regulatory filing, Amedisys (AMED) stated ...

Cotiviti nears $3 billion deal to acquire Edifecs, rejecting higher bid from UnitedHealth. Antitrust concerns cited.

UnitedHealth Group and Amedisys (NASDAQ:AMED) have extended their merger deadline amid scrutiny from the U.S. Department of Justice. The proposed $3.3 billion merger would expand UnitedHealth's ...